After the Fed released minutes of its last meeting, the bond market signaled it fears the Fed will not be aggressive enough with its rate cutting.Market Insiderread more
The Fed minutes also note that "a couple" members wanted a 50 basis point cut, based primarily on the weak inflation readings.The Fedread more
Japanese manufacturing activity shrank for a fourth straight month in August as export orders fell at a sharper pace.Asia Marketsread more
Analysts generally doubt how effective the People Bank of China's latest interest rate announcement will be in significantly helping businesses grow.China Economyread more
The Washington governor had centered his campaign around climate change, calling it "the most urgent challenge of our time."Politicsread more
The inversion is seen by many veteran traders as an important recession omen, though the timing on the eventual downturn is less predictable.Bondsread more
Here's what Nordstrom reported for its fiscal second-quarter earnings.Retailread more
The sexy image that once boosted Victoria's Secret has been haunting L Brands more recently, as women are steering clear of the brand's hot pink, lacy and bejeweled lingerie.Retailread more
Ford is one of four automakers that reached a voluntary agreement with California on fuel efficiency rules, defying Trump and his administration's effort to strip the state of...Autosread more
See which stocks are posting big moves after the bell.Market Insiderread more
"I'd love to say that the optimistic universe is most likely to prevail, but the talking heads talk endlessly about how a recession is inevitable," CNBC's Jim Cramer says.Mad Money with Jim Cramerread more
Johnson & Johnson is just the latest healthcare product company to face a wave of liability lawsuits.
Though it faces billions of dollars in claims alleging its talc baby powder products contained asbestos and caused cancer, the financial hit to the company has yet to be determined.
Johnson & Johnson stock plunged Friday following a report by Reuters that it knew for decades that its baby powder contained asbestos. The company released a statement calling the Reuters article "one-sided, false and inflammatory."
So far, some juries have sided with the company, which maintains that independent tests have shown the product does not contain asbestos. Other juries have been unable to reach verdicts.
In July, a Missouri jury ordered J&J to pay $4.69 billion in a case involving 22 women and their families. A judge affirmed the verdict in August and J&J vowed to appeal it.
Even if that verdict stands, the award would fall short of the biggest medical product liability case to date, which involved a diet pill, Fen-Phen, that was linked to potentially fatal heart problems.